TAK-715 is an orally active and potent p38 MAPK inhibitor with IC50s of 7.1 nM, 200 nM for p38alpha and p38beta, respectively. TAK-715 inhibits casein kinase I (CK1delta/epsilon) to regulate activation of Wnt/beta-catenin signaling. TAK-715 shows good significant efficacy i
Molecular Weight:
399.51
Purity:
99.73
CAS Number:
[303162-79-0]
Formula:
C24H21N3OS
Target:
Casein Kinase,p38 MAPK
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
